, Tracking Stock Market Picks
Enter Symbol:
Biolase Technology, Inc. (BIOL) [hlAlert]

down 65.64 %

Biolase Technology, Inc. (BLTI) rated Buy by FTN Midwest

Posted on: Wednesday,  Mar 5, 2008  8:25 AM ET by FTN Midwest

FTN Midwest rated Buy Biolase Technology, Inc. (NASDAQ: BIOL) on 03/05/2008, when the stock price was $4.25. Since
then, Biolase Technology, Inc. has lost 65.65% as of 10/06/2015's recent price of $1.46.
If you would have followed this FTN Midwest's recommendation on BIOL, you would have lost 65.64% of your investment in 2771 days.

Biolase Technology, Inc. is a medical technology company that develops, manufactures and markets lasers, related products and services focused on technologies for applications and procedures in dentistry and medicine. The Company?s Waterlase Dentistry solution is a group of products, including dental laser systems that allow dentists, periodontists, endodontists, oral surgeons and other specialists to perform a range of dental procedures, including cosmetic and complex surgical applications. Its systems are designed to provide many types of dental procedures. The Waterlase Dentistry solution offers two categories of laser system products: its Waterlase family of products and its Diode family of products, which includes the Company?s ezlase system, as well as related consumables, training and services.

Having access to accurate and timely information is essential for success in today's marketplace. At FTN Midwest, our focus is on providing thorough and objective research to our clients, empowering them to make the well-informed and educated decisions that help enhance their investment process. Our highly experienced team of analytical experts research, examine, and evaluate businesses in several markets, including consumer, health care, business and technology services, and financial service sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/5/2008 8:25 AM Buy
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy